Five trials recently published in mainstream scientific journals that confirm major, statistically significant benefits of ivermectin against COVID-19

Abstract

Major benefits of ivermectin (IVM) treatment for COVID-19 have been known since the results of 20 such randomized controlled trials (RCTs) were reported, as compiled in January 2021. Of the eight of these RCTs that tracked mortality or morbidity in patients with serious cases, seven showed statistically significant clinical improvements. The pooled mortality reduction in these eight RCTs was 78% in the treatment vs. controls groups, and the RCT that used the highest dose of IVM reported a 92% reduction in mortality (p < 0.001). Three RCTs for IVM prevention of COVID-19 and two animal studies of IVM at low human-equivalent doses likewise reported pronounced efficacy. Here we note the recent publication of RCTs for IVM treatment or prevention of COVID-19 in mainstream scientific journals that confirm these previously reported findings.

Download the full four page report: https://osf.io/qru8k/

The secret is slowly trickling out. A proven safe, effective treatment makes the Emergency Use Authorization illegal. There are millions of children on the verge of being jabbed. Spread the word.